# Fast Track Initiative, Inc.

> Fast Track Initiative, Inc. is a VC fund backing Health Care. See 83 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hongo, Japan
- Total investments: 83
- Last investment: Jun 2026
- Lead investor: 28%
- Fund size: $1.1B
- Last fund: Feb 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/fast-track-initiative/about/
- Website: http://www.fti-jp.com/
- Facebook: https://www.facebook.com/Fast-Track-Initiative-Inc-%E3%83%95%E3%82%A1%E3%82%B9%E3%83%88%E3%83%88%E3%83%A9%E3%83%83%E3%82%AF%E3%82%A4%E3%83%8B%E3%82%B7%E3%82%A2%E3%83%86%E3%82%A3%E3%83%96-725798227436525/

Fast Track Initiative, Inc. is a VC fund in Hongo focused on Health Care and Biotechnology. Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.

## Contacts

5 contacts available for Fast Track Initiative, Inc.. Shizune tracks 10 team members at Fast Track Initiative, Inc.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fast-track-initiative?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $345k–$117M |
| Series A | $3M–$113M |
| Series B | $9.5M–$91M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 21 | 25% |
| Biotechnology | 19 | 23% |
| Medical | 14 | 17% |
| Medical Device | 6 | 7% |
| Therapeutics | 5 | 6% |

51 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 20 | 24% |
| Series B | 15 | 18% |
| Seed | 14 | 17% |
| Funding Round | 11 | 13% |
| Series C | 4 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 38 | 46% |
| United States | 3 | 4% |
| United Kingdom | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hiroko Kimura | Principal | 0 | https://shizune.co/investors/profile/hiroko-kimura-72c2 |
| Hiroko Kimura | Principal | 2 | https://shizune.co/investors/profile/hiroko-kimura-a8c0 |
| Keita Kiriya | Analyst | 0 | https://shizune.co/investors/profile/keita-kiriya |
| Koji Yasuda | Life science venture capitalist | 3 | https://shizune.co/investors/profile/koji-yasuda-5521 |
| Koki Fukatsu | Associate | 0 | https://shizune.co/investors/profile/koki-fukatsu |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neusignal Therapeutics | Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M | Series B | Jun 30, 2026 |  |
| NovAccel | NovAccel operates as a deep tech company, ensure a stable supply of medical radioisotopes. | $7.6M | Seed | May 10, 2026 |  |
| Storm Therapeutics | Targeting pathways that modify RNA to deliver novel cancer therapeutics. | $56M | Series C | Apr 16, 2026 |  |
| SONIRE Therapeutics | SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd.. | $18M | Series A | Apr 15, 2026 |  |
| Sonire Therapeutics | SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future. | $18M | Series A | Apr 15, 2026 |  |
| Quali | Quali is dedicated to developing innovative products and solutions that support microsurgery, with the goal of addressing critical challenges in the medical field and improving patient outcomes and overall quality of life. | $11.5M | Series A | Feb 06, 2026 |  |
| Sonire Therapeutics | SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future. | $8M | Series C | Jan 23, 2026 |  |
| Ichirou | Ichirou provides digital senior care support services to connect elderly people with caretakers. It offers caretaker services for different types of support, including housework, hospital care, nursing, hospital and doctor visits, and shopping assistance. | $7.7M | Series B | Sep 11, 2025 |  |
| Metagen Therapeutics | Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M | Series B | Sep 08, 2025 |  |
| Metagen Therapeutics | Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M | Series B | Sep 08, 2025 |  |

10 of 83 investments shown.

## Co-investors
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 19 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 13 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 12 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 11 deals together
- [Nippon Venture Capital](https://shizune.co/investors/profile/nippon-venture-capital) — VC Fund, 10 deals together
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 9 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [All Investors in Japan](https://shizune.co/investors/investors-japan)
- [All VC Funds in Japan](https://shizune.co/investors/vc-funds-japan)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Health Care VC Funds in Japan](https://shizune.co/investors/health-care-vc-funds-japan)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)

## FAQ

### What does Fast Track Initiative, Inc. invest in?

Fast Track Initiative, Inc. invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 83 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Fast Track Initiative, Inc.'s check size?

Fast Track Initiative, Inc. typically joins rounds of $345k–$117M at Seed, $3M–$113M at Series A and $9.5M–$91M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fast Track Initiative, Inc. participates in.

### How do I contact Fast Track Initiative, Inc.?

Public channels for Fast Track Initiative, Inc. include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fast Track Initiative, Inc.?

The team at Fast Track Initiative, Inc. includes Hiroko Kimura (Principal), Hiroko Kimura (Principal) and Keita Kiriya (Analyst), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co